Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humco Holding Group
Texarkana, Texas, USAhumco.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Humco is a diversified pharmaceutical company focused on the development, manufacturing, and commercialization of innovative delivery vehicles and over-the-counter (OTC) medicines. Founded in 1872 and headquartered in Texarkana, Texas, the company serves a global customer base of pharmacists, retailers, and institutional care offices. Humco is a leader in the pharmaceutical compounding market, providing proprietary vehicles like SyrSpend SF for oral liquid formulations and various topical bases. In 2018, the company was acquired by Fagron, a global leader in pharmaceutical compounding, to strengthen its presence in the North American market.
- Therapeutic areas
- EndocrinologyNeurologyDermatology
- Modalities
- Small moleculeTopicalOral liquid
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Humco Holding Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Humco Holding Group.